Various degrees of BRCA-1 promoter CpG methylation have been observed in sporadic breast tumors [16] ranging from ~10 to 85 % depending on tumor type (ductal invasive > lobulo-alveolar) [17–23]. The gene discussed is BRCA1; the disease is breast neoplasm.